| Retirado antes de empezar | Fase 1 | AMG 553Leucemia mieloide aguda recidivante/refractaria | ago 2030 (prevista) |
| Suspendido | Fase 1 | AMG 119Cancer de pulmon microcitico | ene 2028 (prevista) |
| Completado | Fase 3 | ApremilastPsoriasis en placas | ago 2026 (real) |
| Completado | Fase 1 | Evolocumab Drug Substance AVoluntarios sanos · Farmacocinetica | jul 2026 (real) |
| Completado | Fase 1 | AMG 355Tumor solido avanzado | jul 2026 (real) |
| Completado | Fase 1 | Maridebart CafraglutideA Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations | jul 2026 (real) |
| Interrumpido | Fase 3 | Rocatinlimab · ROCKET-ASCENDDermatitis atopica | jul 2026 (real) |
| Completado | Fase 1/2 | sotorasibA Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) | may 2026 (real) |
| Completado | Fase 1 | Maridebart CafraglutideComparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations | may 2026 (real) |
| Interrumpido | Fase 2 | RocatinlimabAsma | may 2026 (real) |
| Interrumpido | Fase 2 | HZN-1116Sindrome de Sjogren | abr 2026 (real) |
| Interrumpido | Fase 3 | RocatinlimabPrurigo nodular | abr 2026 (real) |
| Completado | Fase 1 | AMG 133Insuficiencia hepatica | feb 2026 (real) |
| Completado | Fase 1/2 | AnvumetostatA Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors | feb 2026 (real) |
| Completado | no aplica | Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection | ene 2026 (real) |
| Interrumpido | Fase 1/2 | Bemarituzumab · FORTITUDE-301Tumores solidos | ene 2026 (real) |
| Completado | Fase 1 | AMG 305Tumor solido avanzado | ene 2026 (real) |
| Completado | Fase 4 | TeprotumumabEnfermedad ocular tiroidea | dic 2025 (real) |
| Interrumpido | Fase 1 | AMG 378Voluntarios sanos | dic 2025 (real) |
| Completado | Fase 1 | AMG 133The Effect of AMG 133 on Gastric Emptying | nov 2025 (real) |
| Completado | Fase 1 | TeprotumumabVoluntarios sanos | nov 2025 (real) |
| Completado | Fase 1 | AMG 133A Trial to Assess the Effect of Kidney Impairment on How AMG 133 is Absorbed, Broken Down, and Eliminated by the Body | nov 2025 (real) |
| Interrumpido | Fase 1/2 | Bemarituzumab · FORTITUDE-103A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. | nov 2025 (real) |
| Completado | Fase 3 | Apremilastpsoriasis | oct 2025 (real) |
| Completado | Fase 4 | RomosozumabA Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture. | oct 2025 (real) |
| Interrumpido | Fase 3 | Bemarituzumab · FORTITUDE-102Cancer gastrico · Adenocarcinoma de la union gastroesofagica | oct 2025 (real) |
| Completado | no aplica | TeprotumumabReal World Study to Describe the Effectiveness and Safety of Teprotumumab Among Thyroid Eye Disease Patients | ago 2025 (real) |
| Completado | Fase 3 | Rocatinlimab · ROCKET-OrbitDermatitis atopica | jul 2025 (real) |
| Completado | Fase 4 | PegloticaseGota | jul 2025 (real) |
| Completado | Fase 1 | BlinatumomabStudy to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL) | jul 2025 (real) |
| Completado | Fase 3 | Evolocumab · VESALIUS-CVEnfermedad coronaria del corazon (CHD) | jul 2025 (real) |
| Completado | Fase 3 | Sotorasib · CodeBreak300Cancer colorrectal | jul 2025 (real) |
| Completado | Fase 2 | DaxdilimabMiositis inflamatoria idiopatica | jul 2025 (real) |
| Completado | Fase 3 | Bemarituzumab · FORTITUDE-101Cancer gastrico · Adenocarcinoma de la union gastroesofagica | jun 2025 (real) |
| Interrumpido | Fase 2 | Sotorasib · CodeBreaK201Cancer de pulmon no microcitico | may 2025 (real) |
| Completado | Fase 1 | AMG 133Sobrepeso y obesidad | may 2025 (real) |
| Interrumpido | Fase 2 | DaxdilimabStudy of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus | may 2025 (real) |
| Completado | Fase 1 | RocatinlimabDermatitis atopica | may 2025 (real) |
| Completado | Fase 3 | Rocatinlimab Prefilled Syringe · ROCKET-OutpostDermatitis atopica | abr 2025 (real) |
| Completado | Fase 3 | ABP 206Melanoma | mar 2025 (real) |
| Completado | Fase 3 | apremilast · ESSENCEPsoriasis en placas | feb 2025 (real) |
| Completado | Fase 3 | Rocatinlimab · ROCKET-ASTRODermatitis atopica | feb 2025 (real) |
| Retirado antes de empezar | Fase 2 | RomiplostimEfficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy | feb 2025 (prevista, ya pasada: sin actualizar en el registro) |
| Interrumpido | Fase 2 | HZN-825An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc) | feb 2025 (real) |
| Interrumpido | Fase 2 | HZN-825 BIDA Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis | feb 2025 (real) |
| Completado | Fase 3 | Erenumab Dose 1 · OASIS(CM)Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine | ene 2025 (real) |
| Completado | no aplica | TAP® Micro Select Device · COSMOS-DIGITALObesidad | ene 2025 (real) |
| Completado | Fase 1 | AMG 133A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or Obesity | dic 2024 (real) |
| Completado | Fase 1 | OlpasiranA Study to Assess the Effect of Olpasiran on QT/QTc Intervals in Healthy Participants | nov 2024 (real) |
| Completado | Fase 3 | Rocatinlimab · ROCKET-IgniteDermatitis atopica | nov 2024 (real) |
| Interrumpido | Fase 2 | Efavaleukin alfaColitis ulcerosa | oct 2024 (real) |
| Interrumpido | Fase 2 | Efavaleukin alfaColitis ulcerosa | oct 2024 (real) |
| Completado | Fase 2 | Maridebart CafraglutideDose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus | oct 2024 (real) |
| Completado | Fase 1 | AvacopanA Study of Avacopan in Participants With Normal Renal Function and Participants With End-Stage Renal Disease (ESRD) | oct 2024 (real) |
| Completado | Fase 3 | Rocatinlimab · ROCKET-SHUTTLEDermatitis atopica | sep 2024 (real) |
| Retirado antes de empezar | Fase 1 | SotorasibVoluntarios sanos | sep 2024 (prevista, ya pasada: sin actualizar en el registro) |
| Completado | Fase 1 | Rocatinlimab vial injectionDermatitis atopica | ago 2024 (real) |
| Completado | Fase 1 temprana | MetoprololDermatitis atopica | ago 2024 (real) |
| Completado | Fase 1 | Maridebart CafraglutideObesidad | ago 2024 (real) |
| Completado | Fase 3 | Rocatinlimab · ROCKET-VOYAGERDermatitis Atopica · Dermatitis Atopica Moderada a Severa | ago 2024 (real) |
| Interrumpido | Fase 2 | HZN-825Fibrosis pulmonar idiopatica | jul 2024 (real) |
| Completado | Fase 1 | Tarlatamab · DeLLpro-300A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer | jul 2024 (real) |
| Interrumpido | Fase 4 | Blinatumomableucemia linfoblastica aguda de precursores B | jul 2024 (real) |
| Completado | Fase 1 | CarfilzomibStudy of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia | jun 2024 (real) |
| Interrumpido | Fase 1 | AMG 340Cancer de prostata metastasico resistente a la castracion | jun 2024 (real) |
| Completado | Fase 3 | Rocatinlimab · ROCKET-HorizonDermatitis atopica | jun 2024 (real) |
| Interrumpido | Fase 1 | Bemarituzumab · FORTITUDE-201A Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC With FGFR2b Overexpression (FORTITUDE-201) | may 2024 (real) |
| Interrumpido | Fase 1 | AMG 176AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia | may 2024 (real) |
| Completado | no aplica | Observational Study of Blinatumomab | mar 2024 (real) |
| Completado | Fase 3 | Romiplostim · RECITETrombocitopenia inducida por quimioterapia | ene 2024 (real) |
| Completado | Fase 4 | Pegloticase with MTXInfusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate | ene 2024 (real) |
| Interrumpido | Fase 2 | DaxdilimabNefritis lupica | ene 2024 (real) |
| Completado | Sin fase asignada | A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) | dic 2023 (real) |
| Interrumpido | Fase 1 | AMG 794Cancer de pulmon no microcitico no escamoso · Cancer de ovario epitelial · Tumores solidos malignos avanzados/metastasicos positivos para claudina 6 | dic 2023 (real) |
| Interrumpido | Fase 1 | AMG 176AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia | dic 2023 (real) |
| Completado | Fase 1 | TeprotumumabVoluntarios sanos | nov 2023 (real) |
| Interrumpido | Fase 2 | Daxdilimab · RECAST SLE OLELupus eritematoso sistemico | oct 2023 (real) |
| Completado | Fase 4 | Erenumab · EMBRACEErenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine | oct 2023 (real) |
| Completado | Fase 1 | OlpasiranInsuficiencia renal | oct 2023 (real) |
| Interrumpido | Fase 1/2 | AcapatamabCancer de prostata metastasico resistente a la castracion | oct 2023 (real) |
| Completado | Fase 4 | ErenumabA Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine | sep 2023 (real) |
| Completado | Fase 1 | AMG 256Tumor solido avanzado | sep 2023 (real) |
| Completado | Fase 1 | AMG 786Obesidad | ago 2023 (real) |
| Completado | Fase 3 | ApremilastPhase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP) | ago 2023 (real) |
| Completado | Fase 2 | DaxdilimabAlopecia areata | ago 2023 (real) |
| Completado | Fase 4 | DenosumabLong-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 | jul 2023 (real) |
| Completado | Fase 2 | Rozibafusp AlfaEfficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) | jul 2023 (real) |
| Completado | no aplica | denosumabOsteoporosis | jul 2023 (real) |
| Completado | Fase 1 | AMG 609Single Ascending Dose of AMG 609 in Participants With Non-alcoholic Fatty Liver Disease | jul 2023 (real) |
| Completado | Fase 1 | TarlatamabCancer de pulmon microcitico | jul 2023 (real) |
| Completado | Fase 1 | VIB1116A Study of Single and Multiple Ascending Doses of VIB1116 in Rheumatic Diseases | jul 2023 (real) |
| Interrumpido | Fase 1 | AMG 701Mieloma multiple en recaida o refractario | jun 2023 (real) |
| Interrumpido | Fase 1 | acapatamabCancer de prostata metastasico resistente a la castracion | jun 2023 (real) |
| Completado | Fase 1 | AMG 994Tumores solidos avanzados | jun 2023 (real) |
| Interrumpido | Fase 1 | AMG 199Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers | jun 2023 (real) |
| Interrumpido | Fase 2 | Efavaleukin AlfaEfficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus | may 2023 (real) |
| Completado | Fase 4 | Pegloticase · FORWARD OLgota no controlada · gota cronica | may 2023 (real) |
| Completado | Fase 2 | VIB7734 · RECAST SLEStudy of VIB7734 for the Treatment of Moderate to Severely Active SLE | may 2023 (real) |
| Completado | Fase 1 | AMG 890Enfermedad cardiovascular | abr 2023 (real) |
| Completado | Fase 1 | OlpasiranInsuficiencia hepatica | abr 2023 (real) |
| Completado | Fase 3 | Carfilzomib · ARROW2A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma | mar 2023 (real) |
| Completado | Fase 1 | RomosozumabStudy to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta | mar 2023 (real) |
| Completado | Fase 4 | Carfilzomib + DexamethasoneStudy to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma | mar 2023 (real) |
| Completado | Fase 4 | TEPEZZAenfermedad tiroidea ocular · enfermedad tiroidea ocular cronica (inactiva) | mar 2023 (real) |
| Completado | Fase 1 | TeprotumumabA Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease | feb 2023 (real) |
| Completado | Fase 3 | UstekinumabPsoriasis | feb 2023 (real) |
| Interrumpido | Fase 1 | AMG 427 · 20170528Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia | feb 2023 (real) |
| Completado | Fase 3 | ABP 938Enfermedad vascular coriorretinal | feb 2023 (real) |
| Completado | Fase 1 | BlinatumomabLeucemia linfoblastica aguda | ene 2023 (real) |
| Completado | Fase 4 | Erenumab · INTERROGATEMigrana | ene 2023 (real) |
| Completado | Fase 2 | Tezepelumab Dose 1 · INCEPTIONUrticaria cronica espontanea | dic 2022 (real) |
| Completado | Fase 3 | AdalimumabPsoriasis en placas | dic 2022 (real) |
| Completado | Fase 4 | Erenumab 70 mgA Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache | dic 2022 (real) |
| Completado | Fase 2 | Carfilzomib · SELECTMieloma multiple en recaida o refractario | nov 2022 (real) |
| Interrumpido | Fase 1 | TEPEZZAA Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc) | nov 2022 (real) |
| Completado | Fase 1 | maridebart cafraglutideObesidad | nov 2022 (real) |
| Retirado antes de empezar | Fase 3 | ABP 215A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cancer | nov 2022 (prevista, ya pasada: sin actualizar en el registro) |
| Completado | no aplica | Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan | oct 2022 (real) |
| Interrumpido | Fase 1/2 | Efavaleukin AlfaSafety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease | oct 2022 (real) |
| Completado | Fase 1 | Immediate Release · INTREPID-1Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma | oct 2022 (real) |
| Completado | Fase 1 | OmeprazoleVoluntarios sanos | sep 2022 (real) |
| Completado | Fase 2 | VIB4920 · SSA Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome | sep 2022 (real) |
| Completado | Fase 4 | PegloticaseGota Incontrolada | ago 2022 (real) |
| Completado | no aplica | APARTPsoriasis | ago 2022 (real) |
| Completado | Fase 1 | AvacopanVoluntarios sanos | ago 2022 (real) |
| Completado | Fase 3 | AMG 510Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200). | ago 2022 (real) |
| Completado | Fase 1 | AMG 404Tumor solido avanzado | jul 2022 (real) |
| Completado | Fase 2 | BelataceptA Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant | jul 2022 (real) |
| Completado | Fase 3 | ABP 938A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD] | jul 2022 (real) |
| Completado | Fase 1 | SotorasibVoluntarios sanos | jul 2022 (real) |
| Completado | Fase 3 | ABP 959 · DAHLIAHemoglobinuria paroxistica nocturna | jul 2022 (real) |
| Completado | Fase 4 | RAVICTITrastorno del ciclo de la urea | jul 2022 (real) |
| Interrumpido | Fase 1 | AMG 910Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma | jun 2022 (real) |
| Completado | Fase 3 | ApremilastPsoriasis | abr 2022 (real) |
| Interrumpido | Fase 1 | AMG 420 · AMG420Assessment of AMG 420 in Subjects With Relapsed and/or Refractory Multiple Myeloma | abr 2022 (real) |
| Completado | Fase 1 | AMG 133Voluntarios sanos | abr 2022 (real) |
| Interrumpido | Fase 3 | DenosumabOsteogenesis imperfecta (OI) | mar 2022 (real) |
| Interrumpido | Fase 3 | Denosumab · OIMulticenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI | mar 2022 (real) |
| Completado | Fase 3 | Evolocumab · FOURIER OLEFurther Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension | mar 2022 (real) |
| Completado | Fase 1 | SotorasibInsuficiencia hepatica | mar 2022 (real) |
| Interrumpido | Fase 3 | EvolocumabFourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries | mar 2022 (real) |
| Completado | Fase 1 | SotorasibVoluntarios sanos | feb 2022 (real) |
| Completado | Fase 1/2 | Talimogene Laherparepvec · MASTERKEY-318Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611 | feb 2022 (real) |
| Completado | Fase 1 | Talimogene LaherparepvecStudy of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors | ene 2022 (real) |
| Completado | Fase 3 | ABP 654Psoriasis en placas | ene 2022 (real) |
| Completado | Fase 1 | AMG 510AMG 510 Ethnic Sensitivity Study (CodeBreaK 105). | dic 2021 (real) |
| Completado | Fase 2 | VIB4920 · MIDORAArtritis reumatoide | dic 2021 (real) |
| Completado | Fase 2 | OlpasiranEnfermedad cardiovascular | dic 2021 (real) |
| Completado | Fase 3 | DenosumabEvaluar la seguridad y eficacia de denosumab en sujetos pediatricos con · Osteoporosis inducida por glucocorticoides | dic 2021 (real) |
| Retirado antes de empezar | Fase 2 | InebilizumabSafety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased Donor | dic 2021 (prevista, ya pasada: sin actualizar en el registro) |
| Completado | Fase 1 | ABP 501-HCFA Study Comparing the Pharmacokinetics (PK) of ABP 501 40 mg/0.4 mL (ABP 501-HCF) and ABP 501 40 mg/0.8 ml (ABP 501-LCF) in Healthy Adult Participants | nov 2021 (real) |
| Completado | Fase 1 | AMG 334 Dose 1AMG 334 20160172 Pediatric Migraine PK Study. | nov 2021 (real) |
| Completado | Fase 1 | OlpasiranA Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a) | nov 2021 (real) |
| Completado | no aplica | Post-Marketing Surveillance Study of OTEZLAPsoriasis | oct 2021 (real) |
| Completado | no aplica | APPRECIATEPsoriasis | oct 2021 (real) |
| Completado | Fase 4 | Apremilast · MOSAICArtritis psoriasica | oct 2021 (real) |
| Completado | no aplica | Apremilast · PREVAILA Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological Treatment | oct 2021 (real) |
| Completado | Fase 1 | Efavaleukin AlfaLupus eritematoso sistemico | oct 2021 (real) |
| Completado | Fase 1 | RosuvastatinVoluntarios sanos | oct 2021 (real) |
| Completado | Fase 4 | AMG334Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients | oct 2021 (real) |
| Interrumpido | Sin fase asignada | Biobeat Wrist Watch · HF-eVOLUTIONInsuficiencia cardiaca | oct 2021 (real) |
| Completado | no aplica | Registry Study for Talimogene Laherparepvec | sep 2021 (real) |
| Completado | Fase 3 | Apremilast · DISCREETPsoriasis | sep 2021 (real) |
| Completado | Fase 1 | blinatumomabLinfoma no Hodgkin | sep 2021 (real) |
| Completado | Fase 2 | Talimogene laherparepvecMelanoma | ago 2021 (real) |
| Completado | no aplica | Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States | ago 2021 (real) |
| Completado | Fase 3 | Apremilast · COMMUNITYCOVID-19 | ago 2021 (real) |
| Interrumpido | Fase 4 | ErenumabEffect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine | jul 2021 (real) |
| Completado | no aplica | Apremilast · REALIZEPsoriasis | jul 2021 (real) |
| Retirado antes de empezar | Fase 3 | RomiplostimStudy of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma. | jul 2021 (prevista, ya pasada: sin actualizar en el registro) |
| Completado | Fase 4 | PegloticaseStudy of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant | jul 2021 (real) |
| Interrumpido | Fase 1 | AMG 596Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma | jul 2021 (real) |
| Completado | no aplica | HEYMANSChart Review of Repatha® in Subjects With Hyperlipidaemia | jun 2021 (real) |
| Completado | Fase 3 | Evolocumab · HAUSER-OLESafety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia) | jun 2021 (real) |
| Completado | no aplica | PERSEIDAmCRC RAS de tipo salvaje | may 2021 (real) |
| Completado | Fase 1 | TEPEZZAA Study of TEPEZZA Subcutaneous Administration in Healthy Adults | may 2021 (real) |
| Completado | no aplica | Apremilast · APPRAISEStudy to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE) | abr 2021 (real) |
| Completado | Fase 4 | Pegloticase · MIRROR RCTGota | mar 2021 (real) |
| Interrumpido | Fase 3 | Talimogene Laherparepvec · MASTERKEY-265Melanoma | mar 2021 (real) |
| Completado | Fase 4 | Apremilast · EMBRACEPsoriasis | feb 2021 (real) |
| Completado | no aplica | Apremilast · DARWINPsoriasis en placas | ene 2021 (real) |
| Completado | Fase 2 | ApremilastA Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pustulosis | ene 2021 (real) |
| Completado | Fase 2 | AvacopanEvaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) | ene 2021 (real) |
| Completado | no aplica | SILQCancer colorrectal metastasico | dic 2020 (real) |
| Interrumpido | Fase 1 temprana | EmerfetamabLeucemia mieloide aguda | dic 2020 (real) |
| Interrumpido | no aplica | cvMOBIUSThe Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) | dic 2020 (real) |
| Completado | Fase 3 | EvolocumabImaging of Coronary Plaques in Participants Treated With Evolocumab | dic 2020 (real) |
| Completado | no aplica | Osteonecrosis of the Jaw (ONJ) Case RegistryOsteonecrosis de la mandibula | dic 2020 (real) |
| Interrumpido | no aplica | Study to Evaluate the Safety of Repatha® in Pregnancy | nov 2020 (real) |
| Completado | Fase 1 | Blinatumomab · HARBOURLinfoma difuso de celulas B grandes (DLBCL) recidivante o refractario | nov 2020 (real) |
| Interrumpido | Fase 1 | AMG 330Leucemia mieloide aguda recidivante o refractaria | oct 2020 (real) |
| Completado | Fase 1 | AMG 510Participantes sanos | sep 2020 (real) |
| Interrumpido | no aplica | evolocumabEvolocumab Pregnancy Exposure Registry | sep 2020 (real) |
| Completado | Fase 1 | Talimogene laherparepvecStudy to Evaluate the Safety/ Efficacy of T-VEC in Japanese Subjects With Unresectable Stage IIIB-IV Malignant Melanoma | ago 2020 (real) |
| Completado | Fase 1 | VIB7734A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis | jul 2020 (real) |
| Interrumpido | Fase 2 | CCX140-BGlomeruloesclerosis focal y segmentaria | jun 2020 (real) |
| Completado | Fase 1 | AMG 510Voluntarios sanos | jun 2020 (real) |
| Completado | Fase 3 | Teprotumumab · OPTIC-XTreatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study | jun 2020 (real) |
| Completado | Fase 1 | Talimogene LaherparepvecStudy of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases | may 2020 (real) |
| Interrumpido | Fase 2 | TezepelumabDermatitis atopica | may 2020 (real) |
| Completado | Fase 3 | ApremilastPsoriasis en placas | may 2020 (real) |
| Completado | Fase 1 | CCX872-BCancer de pancreas | may 2020 (real) |
| Interrumpido | Fase 3 | evolocumabHipercolesterolemia primaria · Dislipidemia mixta | abr 2020 (real) |
| Completado | Fase 3 | EtelcalcetideHiperparatiroidismo secundario · enfermedad renal cronica | abr 2020 (real) |
| Completado | no aplica | An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US | mar 2020 (real) |
| Completado | Fase 1 | AMG 510Voluntarios sanos | mar 2020 (real) |
| Completado | no aplica | Real-world Use of Carfilzomib Among Multiple Myeloma Patients in EuropeMieloma multiple | mar 2020 (real) |
| Completado | Fase 3 | ErenumabA Controlled Trial of Erenumab in Migraine Prevention | mar 2020 (real) |
| Completado | Fase 2/3 | BlinatumomabStudy to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL | mar 2020 (real) |
| Completado | Fase 3 | Apremilast · ADVANCEPsoriasis | mar 2020 (real) |
| Completado | Fase 1 | CC-11050Voluntarios sanos | feb 2020 (real) |
| Interrumpido | no aplica | THRIVEObservational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs) | feb 2020 (real) |
| Completado | Fase 2 | CCX140-BA Study of CCX140-B in Subjects With FSGS | feb 2020 (real) |
| Retirado antes de empezar | Fase 3 | IvabradineTrasplante cardíaco, frecuencia cardíaca en reposo elevada | feb 2020 (prevista, ya pasada: sin actualizar en el registro) |
| Completado | Fase 1 | AMG 510Participantes sanos | ene 2020 (real) |
| Completado | Fase 1 | AvacopanElectrocardiografia | ene 2020 (real) |
| Interrumpido | Fase 2 | DexamethasoneA Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers | ene 2020 (real) |
| Completado | no aplica | APRILPsoriasis | dic 2019 (real) |
| Completado | Fase 1 | AMG 510Voluntarios sanos | dic 2019 (real) |
| Completado | Fase 1 | AMG 598Obesidad | dic 2019 (real) |
| Interrumpido | Fase 1/2 | Efavaleukin alfaSafety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis | dic 2019 (real) |
| Completado | Fase 3 | etanercept pre-filled syringe…Artritis reumatoide | dic 2019 (real) |
| Completado | Fase 1 | AMG 510Voluntarios sanos | dic 2019 (real) |
| Completado | Fase 4 | evolocumab · RAMANSafety and Tolerability of Repatha® (Evolocumab) in Indian Participants With Homozygous Familial Hypercholesterolemia | nov 2019 (real) |
| Completado | Fase 1 | AMG 510Voluntarios sanos | nov 2019 (real) |
| Completado | Fase 1 | AMG 510Voluntarios sanos | nov 2019 (real) |
| Completado | Fase 3 | Evolocumab · HAUSER-RCTTrial Assessing Efficacy, Safety and Tolerability of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition in Paediatric Subjects With Genetic Low-Density Lipoprotein (LDL) Disorders | nov 2019 (real) |
| Completado | Fase 1 | AMG 510Participantes sanos | nov 2019 (real) |
| Completado | no aplica | APPROPIATEPsoriasis | nov 2019 (real) |
| Completado | Fase 1 | CarfilzomibMieloma multiple | oct 2019 (real) |
| Completado | Fase 4 | Pegloticase · MIRROR OLgota | oct 2019 (real) |
| Completado | Fase 1 | Rozibafusp AlfaArtritis reumatoide | oct 2019 (real) |
| Interrumpido | Fase 2 | BlinatumomabEffect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT) | sep 2019 (real) |
| Interrumpido | Fase 1/2 | OprozomibMieloma multiple | sep 2019 (real) |
| Completado | Fase 3 | Avacopan · ADVOCATEA Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis | sep 2019 (real) |
| Completado | Fase 3 | BlinatumomabLeucemia linfoblastica aguda | ago 2019 (real) |
| Completado | no aplica | Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic AcidOsteonecrosis de mandibula · Infeccion que conduce a hospitalizacion | ago 2019 (real) |
| Interrumpido | Fase 1 | AMG 397Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies | jul 2019 (real) |
| Completado | Fase 3 | BlinatumomabLeucemia linfoblastica aguda | jul 2019 (real) |
| Completado | Fase 3 | Dexamethasone · CANDORMieloma multiple en recaida · Mieloma multiple refractario | jul 2019 (real) |
| Completado | Fase 3 | EvolocumabSafety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia | jul 2019 (real) |
| Completado | Fase 3 | ABP 798 · JASMINELinfoma no Hodgkin | jun 2019 (real) |
| Interrumpido | Fase 1/2 | OprozomibMieloma multiple | jun 2019 (real) |
| Completado | Fase 2 | Talimogene LaherparepvecEfficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Melanoma | abr 2019 (real) |
| Completado | Fase 4 | IvabradineInsuficiencia cardiaca (IC) | abr 2019 (real) |
| Interrumpido | Fase 1 | AMG 986 IVInsuficiencia cardiaca · Voluntarios sanos | abr 2019 (real) |
| Completado | Fase 1 | AMG 592A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of AMG 592 in Healthy Japanese Participants | abr 2019 (real) |
| Completado | Fase 3 | romosozumab HCP administration…Osteoporosis posmenopausica | abr 2019 (real) |
| Interrumpido | Fase 1 | VIB9600A Phase1 Study of VIB9600 | abr 2019 (real) |
| Completado | Fase 2 | BlinatumomabSafety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma | abr 2019 (real) |
| Completado | Fase 3 | Teprotumumab · OPTICTreatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study | feb 2019 (real) |
| Completado | Fase 1/2 | BlinatumomabStudy of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | feb 2019 (real) |
| Completado | Fase 1 | EtelcalcetideHiperparatiroidismo secundario | feb 2019 (real) |
| Completado | no aplica | apremilast · APOLOA Study of the Real-life Management of Psoriatic Arthritis Patients Treated With Otezla® (Apremilast) in Belgium | dic 2018 (real) |
| Completado | no aplica | Apremilast · OTELOPsoriasis | dic 2018 (real) |
| Completado | Fase 1 | AMG 224Mieloma multiple | nov 2018 (real) |
| Completado | Fase 3 | DexamethasoneCarfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma | nov 2018 (real) |
| Completado | Fase 1 | EtelcalcetideA Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis | oct 2018 (real) |
| Completado | Fase 2 | AMG 301Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention | oct 2018 (real) |
| Completado | Fase 3 | ABP 798Study to Assess if ABP 798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis (RA) Compared to Rituximab | oct 2018 (real) |
| Completado | Fase 1 | AvacopanInsuficiencia hepatica | sep 2018 (real) |
| Completado | Fase 1 | AMG 570Lupus eritematoso sistemico | sep 2018 (real) |
| Completado | Fase 3 | RomiplostimLong-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP) | ago 2018 (real) |
| Completado | Fase 3 | Apremilast · STYLEPsoriasis | ago 2018 (real) |
| Completado | Fase 3 | DenosumabOpen-Label Access Protocol of Denosumab for Subjects With Advanced Cancer | ago 2018 (real) |
| Completado | no aplica | VISIONCancer colorrectal metastasico | ago 2018 (real) |
| Completado | no aplica | LAPIS-PsAStudy of Apremilast Use in Patients With Psoriatic Arthritic in Practice Conditions | jul 2018 (real) |
| Completado | Fase 2 | Evolocumab · OSLERHipercolesterolemia | jun 2018 (real) |
| Completado | Fase 1 | FPA144A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer | jun 2018 (real) |
| Completado | Fase 1 | VIB4920A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis | may 2018 (real) |
| Completado | Fase 2 | DenosumabCancer · Tumores de celulas gigantes · Tumor de celulas gigantes del hueso · Tumores de celulas gigantes benignos | may 2018 (real) |
| Completado | Fase 2/3 | Evolocumab · TAUSSIGTrial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders | may 2018 (real) |
| Completado | Fase 3 | ABP 710Artritis reumatoide | abr 2018 (real) |
| Completado | Fase 3 | Evolocumab · ANITSCHKOWEffects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a)) | abr 2018 (real) |
| Completado | Fase 1 | AMG 986Insuficiencia cardiaca | mar 2018 (real) |
| Completado | Fase 3 | EvolocumabHipercolesterolemia | mar 2018 (real) |
| Completado | Fase 3 | RomosozumabOsteoporosis posmenopausica | feb 2018 (real) |
| Completado | Fase 1 | CCX168A Study of CCX168 in Japanese and Caucasian Healthy Adult Males | ene 2018 (real) |
| Completado | Fase 3 | EtanerceptEtanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis | ene 2018 (real) |
| Completado | Fase 4 | Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip ReplacementOsteoporosis | dic 2017 (real) |
| Completado | Fase 3 | Evolocumab · BERSONSafety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia | dic 2017 (real) |
| Interrumpido | Fase 1 | AMG 211A Phase 1 Study of AMG 211 in Participants With Advanced Gastrointestinal Cancer | nov 2017 (real) |
| Completado | Fase 1 | Talimogene Laherparepvec · MASTERKEY232Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY232 / KEYNOTE-137) | nov 2017 (real) |
| Completado | no aplica | AMG 162 · PILOTECharacteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France | oct 2017 (real) |
| Completado | Fase 3 | Darbepoetin alfa · START-CKDAnemia en pacientes con enfermedad renal cronica no sometidos a dialisis | oct 2017 (real) |
| Completado | Fase 1 | ErenumabTo Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients | sep 2017 (real) |
| Completado | Fase 3 | ApremilastA Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease | sep 2017 (real) |
| Completado | Fase 2 | Apremilast · UCColitis ulcerosa | sep 2017 (real) |
| Completado | Fase 3 | Commercial Formulation…Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis | sep 2017 (real) |
| Completado | Fase 2 | ApremilastPsoriasis | sep 2017 (real) |
| Interrumpido | Fase 3 | DenosumabCancer de mama | ago 2017 (real) |
| Completado | Fase 4 | Etanerceptpsoriasis en placas | ago 2017 (real) |
| Completado | Fase 3 | Evolocumab · GAUSS-4Hipercolesterolemia | ago 2017 (real) |
| Completado | Fase 3 | Evolocumab · BANTINGHipercolesterolemia · Dislipidemia mixta · Diabetes tipo 2 | ago 2017 (real) |
| Completado | Fase 2 | Talimogene Laherparepvec · TVEC-325Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma | jun 2017 (real) |
| Completado | Fase 3 | Cysteamine Bitartrate…Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) | jun 2017 (real) |
| Completado | Fase 1 | AMG 592A Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AMG 592 in Healthy Participants | jun 2017 (real) |
| Completado | Fase 3 | Carfilzomib · ARROWMieloma multiple | jun 2017 (real) |
| Completado | no aplica | A Study of Otezla® in Patients With Plaque Psoriasis Under Routine ConditionsPsoriasis | jun 2017 (real) |
| Interrumpido | Fase 3 | Darbepoetin alfaCancer de pulmon no microcitico · anemia · cancer · cancer de pulmon | jun 2017 (real) |
| Completado | Fase 2 | ErenumabA Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention. | may 2017 (real) |
| Completado | Fase 2 | CarfilzomibMieloma multiple · Tumor solido | may 2017 (real) |
| Completado | Fase 2 | AMG 714Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease | abr 2017 (real) |
| Completado | Fase 3 | interferon γ-1b · STEADFASTAtaxia de Friedreich | mar 2017 (real) |
| Completado | Fase 3 | Interferon γ-1b · STEADFASTSafety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia Study | mar 2017 (real) |
| Completado | Fase 3 | Darbepoetin AlfaSíndrome mielodisplásico (SMD) | mar 2017 (real) |
| Completado | Fase 3 | CinacalcetExtension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis | mar 2017 (real) |
| Interrumpido | Fase 2 | Cysteamine BitartrateA Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease | mar 2017 (real) |
| Completado | Fase 3 | Romosozumab · ARCHStudy to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis | feb 2017 (real) |
| Completado | Fase 4 | HPN-100Trastornos del ciclo de la urea | feb 2017 (real) |
| Completado | Fase 2 | AMG 714A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease | feb 2017 (real) |
| Completado | Fase 2 | ErenumabTreadmill Cardiovascular Safety Study of Erenumab (AMG 334) | ene 2017 (real) |
| Completado | Fase 3 | RP103Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis | dic 2016 (real) |
| Interrumpido | Fase 1 | AMG 228Safety Study of AMG 228 to Treat Solid Tumors | dic 2016 (real) |
| Completado | no aplica | Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer PatientsCancer colorrectal metastasico RAS de tipo salvaje | nov 2016 (real) |
| Completado | Fase 1 | Apremilast IRVoluntarios sanos | nov 2016 (real) |
| Completado | Fase 3 | Evolocumab · EBBINGHAUSDislipidemia | nov 2016 (real) |
| Completado | Fase 3 | Evolocumab · FOURIERDislipidemia | nov 2016 (real) |
| Completado | Fase 3 | EtelcalcetideHiperparatiroidismo secundario | nov 2016 (real) |
| Completado | Fase 3 | Interferon γ-1b · STEADFASTSafety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia | nov 2016 (real) |
| Retirado antes de empezar | Fase 1 | Darbepoetin alfaAnemia · Enfermedad renal cronica | nov 2016 (prevista, ya pasada: sin actualizar en el registro) |
| Completado | no aplica | Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy | oct 2016 (real) |
| Completado | Fase 4 | RAVICTITrastorno del ciclo de la urea | oct 2016 (real) |
| Interrumpido | Fase 2 | AMG 337Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors | oct 2016 (real) |
| Completado | Fase 2 | Cysteamine Bitartrate · MITO-001Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease | oct 2016 (real) |
| Completado | Fase 1 | ErenumabErenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females | sep 2016 (real) |
| Completado | Fase 3 | Erenumab · STRIVEStudy to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention | sep 2016 (real) |
| Completado | Fase 3 | EvolocumabHipercolesterolemia | sep 2016 (real) |
| Completado | Fase 1/2 | Talimogene laherparepvecMelanoma | ago 2016 (real) |
| Completado | Fase 1 | SumatriptanVoluntarios sanos | ago 2016 (real) |
| Interrumpido | Fase 1/2 | oprozomibOpen-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies | ago 2016 (real) |
| Completado | Fase 1 | ApremilastFarmacocinetica | ago 2016 (real) |
| Completado | Fase 1 | TeprotumumabEdema macular diabetico | ago 2016 (real) |
| Completado | Fase 1/2 | CarfilzomibCancer de pulmon microcitico en estadio extenso | ago 2016 (real) |
| Completado | Fase 2 | DenosumabCancer de pulmon no microcitico | jul 2016 (real) |
| Completado | Fase 1/2 | Carfilzomib · CHAMPION 1Mieloma multiple | jul 2016 (real) |
| Completado | Fase 3 | DenosumabCancer · Neoplasias hematologicas · Mieloma multiple · Oncologia · Metastasis oseas · Lesiones oseas del mieloma multiple | jul 2016 (real) |
| Completado | Fase 3 | Carfilzomib · CLARIONMieloma multiple | jul 2016 (real) |
| Completado | Fase 3 | Evolocumab · GLAGOVHipercolesterolemia | jul 2016 (real) |
| Completado | Fase 3 | Erenumab · ARISEStudy to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention | jul 2016 (real) |
| Interrumpido | Fase 3 | Cinacalcet HClEnfermedad renal cronica · Hiperparatiroidismo secundario | jun 2016 (real) |
| Completado | Fase 3 | Denosumab · GIOPEfficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids | jun 2016 (real) |
| Interrumpido | Fase 2 | Cinacalcet hydrochlorideSafety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism | jun 2016 (real) |
| Completado | Fase 3 | DenosumabEvaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss | may 2016 (real) |
| Completado | Fase 3 | ABP 980 · LilacCancer de mama | may 2016 (real) |
| Completado | Fase 1 | AMG 282A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Chronic Rhinosinusitis With Nasal Polyps | may 2016 (real) |
| Completado | Fase 2 | CCX168 10 mgClinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis | abr 2016 (real) |
| Completado | Fase 1 | AMG 595AMG 595 First-in-Human in Recurrent Gliomas | abr 2016 (real) |
| Completado | Fase 3 | ABP 501Artritis reumatoide | abr 2016 (real) |
| Completado | Fase 1 | CCX168A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications | mar 2016 (real) |
| Interrumpido | Fase 3 | AMG 386TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer | mar 2016 (real) |
| Completado | Fase 1 | AMG 557Artritis lupica, Lupus eritematoso sistemico | mar 2016 (real) |
| Completado | Fase 1 | Carfilzomib · CHAMPION 2Mieloma Multiple | mar 2016 (real) |
| Completado | Fase 2 | teprotumumabTeprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease | mar 2016 (real) |
| Completado | Fase 1 | Apremilast TabletVoluntarios sanos | feb 2016 (real) |
| Completado | Fase 2 | ErenumabA Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention | feb 2016 (real) |
| Completado | Fase 3 | Romosozumab · BRIDGEOsteoporosis en hombres | feb 2016 (real) |
| Completado | Fase 4 | Apremilast · UNVEILA Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis. | feb 2016 (real) |
| Completado | Fase 1 | CCX168A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168 | feb 2016 (real) |
| Completado | Fase 1 | AMG 581 · MADMultiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective | feb 2016 (real) |
| Interrumpido | Fase 1 | AMG 357Artritis reumatoide | feb 2016 (real) |
| Completado | Fase 2 | Talimogene laherparepvecMelanoma | ene 2016 (real) |
| Interrumpido | Fase 1 | EtanerceptEffects of Denosumab on the Pharmacokinetics of Etanercept | ene 2016 (real) |
| Interrumpido | Fase 3 | BlinatumomabLeucemia linfoblastica aguda de precursores B en recaida/refractaria | dic 2015 (real) |
| Completado | Fase 3 | Romosozumab · FRAMEEfficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis | dic 2015 (real) |
| Completado | Fase 1 | ABP 501Voluntarios sanos | dic 2015 (real) |
| Completado | Fase 3 | Atorvastatin · GAUSS-3Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3 | nov 2015 (real) |
| Completado | Fase 1/2 | AMG 337A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects | nov 2015 (real) |
| Completado | no aplica | Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training | nov 2015 (real) |
| Completado | Fase 1/2 | AMG 386Cancer de pulmon no microcitico | nov 2015 (real) |
| Completado | Fase 4 | EtanerceptPsoriasis en placas | nov 2015 (real) |
| Completado | Fase 1 | AMG 337A Study of AMG 337 in Subjects With Advanced Solid Tumors | oct 2015 (real) |
| Interrumpido | Fase 4 | Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid ArthritisPersistencia a Enbrel | oct 2015 (real) |
| Completado | Fase 1 | AMG 581 · FIHSingle-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581 | oct 2015 (real) |
| Completado | Fase 2 | ApremilastEfficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis | oct 2015 (real) |
| Completado | no aplica | RAYOS · SUNRAYArtritis reumatoide | oct 2015 (real) |
| Completado | Fase 2 | CCX168A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis | oct 2015 (real) |
| Completado | Fase 1 | CinacalcetStudy to Evaluate Cinacalcet in Children With Chronic Kidney Disease | sep 2015 (real) |
| Completado | Fase 2 | CCX168Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade | sep 2015 (real) |
| Completado | no aplica | Observational Study of Denosumab (Prolia®) in Postmenopausal Women With Osteoporosis | ago 2015 (real) |
| Completado | Fase 1 | CarfilzomibTumor solido · Neoplasias hematologicas · Insuficiencia hepatica | ago 2015 (real) |
| Completado | Fase 3 | CarboplatinEfficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer | jul 2015 (real) |
| Completado | Fase 3 | DenosumabExtension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis | jul 2015 (real) |
| Completado | Fase 3 | EtelcalcetideHiperparatiroidismo secundario | jul 2015 (real) |
| Completado | Fase 3 | DenosumabOsteoporosis postmenopáusica | jul 2015 (real) |
| Interrumpido | Fase 4 | Etanercept · ROCkIESEvaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab | jun 2015 (real) |
| Completado | no aplica | Medical Records Review to Describe the Patterns of KRAS Testing and Vectibix Use in EuropeCancer colorrectal metastasico | jun 2015 (real) |
| Interrumpido | Fase 3 | Rilotumumab · RILOMET-2Cancer gastrico | jun 2015 (real) |
| Interrumpido | Fase 4 | EtanerceptPsoriasis | may 2015 (real) |
| Completado | Fase 2 | BlinatumomabALL de precursores B Filadelfia positiva recidivante/refractaria | may 2015 (real) |
| Interrumpido | Fase 1 | OprozomibA Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies | may 2015 (real) |
| Completado | no aplica | Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw | may 2015 (real) |
| Interrumpido | Fase 2 | BrodalumabAsma | may 2015 (real) |
| Completado | no aplica | DenosumabOsteoporosis posmenopausica | may 2015 (real) |
| Completado | Fase 3 | Romozosumab · STRUCTUREAn Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women | may 2015 (real) |
| Retirado antes de empezar | Fase 2 | Brodalumab 210 mgStudy of Efficacy and Safety of Brodalumab Compared With Placebo in Subjects With Axial Spondyloarthritis | may 2015 (real) |
| Completado | no aplica | ADAPTATIONObservational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis | abr 2015 (real) |
| Completado | no aplica | SHADEStudy of Haemodialysis Patients Switching From Aranesp to Biosimilar | abr 2015 (real) |
| Completado | Fase 1 | PanitumumabTumor solido | mar 2015 (real) |
| Completado | Fase 4 | 800 mg ibuprofenOpen-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis | mar 2015 (real) |
| Retirado antes de empezar | Fase 1/2 | OprozomibPhase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma | mar 2015 (real) |
| Completado | Fase 3 | Apremilast 30 mgSafety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis | feb 2015 (real) |
| Completado | Fase 3 | Evolocumab · FLOREYHiperlipidemia primaria y dislipidemia mixta | feb 2015 (real) |
| Completado | Fase 3 | Darbepoetin alfaSindromes mielodisplasicos | feb 2015 (real) |
| Completado | Fase 4 | VIMOVO 250A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA) | feb 2015 (real) |
| Completado | Fase 3 | RP103Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in Cystinosis | feb 2015 (real) |
| Completado | Fase 3 | RomiplostimPurpura trombocitopenica idiomatica · Trombocitopenia · Trombocitopenia en sujetos pediatricos con purpura trombocitopenica inmunitaria (idiomatica) (ITP) · Trombocitopenia en sujetos con purpura trombocitopenica inmunitaria (idiomatica) (ITP) · Purpura trombocitopenica · Trombocitopenia inmunitaria | feb 2015 (real) |
| Completado | no aplica | Database assessment of…Uso fuera de etiqueta de XGEVA | feb 2015 (real) |
| Completado | no aplica | Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL) | ene 2015 (real) |
| Completado | Fase 4 | DenosumabOsteoporosis posmenopausica | ene 2015 (real) |
| Completado | Fase 1/2 | OprozomibMieloma multiple | ene 2015 (real) |
| Completado | Fase 1 | Arm 1- Dose EscalationA Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors | dic 2014 (real) |
| Completado | Fase 2 | AbrilumabEnfermedad de Crohn | dic 2014 (real) |
| Completado | Fase 1 | EvolocumabEstimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab | dic 2014 (real) |
| Completado | Fase 2 | VINECancer de mama | dic 2014 (real) |
| Completado | Fase 1 | [14C]CCX168A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX168 in Healthy Participants | dic 2014 (real) |
| Completado | Fase 2 | ApremilastEfficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis | nov 2014 (real) |
| Completado | Fase 3 | EtelcalcetideHead-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet | nov 2014 (real) |
| Completado | Fase 3 | Carfilzomib · ENDEAVORMieloma multiple | nov 2014 (real) |
| Completado | no aplica | European Physician Survey of EGFR Inhibitor Prescribing PatternsCancer colorrectal metastasico | nov 2014 (real) |
| Retirado antes de empezar | Fase 4 | denosumabTumor solido · Enfermedad osea metastatica | nov 2014 (real) |
| Interrumpido | Fase 3 | Rilotumumab · RILOMET-1Cancer gastrico | nov 2014 (real) |
| Completado | Fase 3 | ABP 501artritis reumatoide | nov 2014 (real) |
| Interrumpido | Fase 1 | AMG 876Diabetes | nov 2014 (real) |
| Completado | Fase 2 | RomosozumabOsteoporosis posmenopausica (PMO) | oct 2014 (real) |
| Completado | Fase 3 | DenosumabCancer de mama | oct 2014 (real) |
| Interrumpido | Fase 1 | AMG 333Phase I, Double-Blind,Placebo, MAD Study to Evaluate the Safety, Tolerability, PK, and PD of AMG 333 in Healthy Subjects and Migraine Subjects | oct 2014 (real) |
| Completado | Fase 1/2 | CarfilzomibPhase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma | oct 2014 (real) |
| Completado | Fase 2 | ErenumabStudy to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention | sep 2014 (real) |
| Completado | Fase 3 | Romosozumab 90 mgA Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis | sep 2014 (real) |
| Completado | Fase 1 | Arm 1- Dose EscalationStudy Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia | sep 2014 (real) |
| Completado | Fase 1 | AMG 333Single-Ascending Dose Study of AMG 333 in Healthy Subjects and Subjects With Migraines | sep 2014 (real) |
| Completado | Fase 1 | AMG 357A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food Effect of AMG 357 in Healthy Subjects | sep 2014 (real) |
| Interrumpido | Fase 3 | AMG386 plus PLDCancer de trompa de Falopio · Cancer de ovario · Carcinoma peritoneal primario | ago 2014 (real) |
| Completado | Fase 3 | Adalimumabpsoriasis | ago 2014 (real) |
| Completado | Fase 1 | Denosumab CP4Voluntarios sanos | ago 2014 (real) |
| Completado | Fase 2 | CCX140-BA Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy | ago 2014 (real) |
| Completado | Fase 1/2 | BlinatumomabLeucemia linfoblastica aguda | ago 2014 (real) |
| Completado | Fase 1 | ErenumabAscending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine Patients | jul 2014 (real) |
| Completado | Fase 3 | ApremilastPsoriasis · Artritis psoriásica | jul 2014 (real) |
| Completado | Fase 1 | DenosumabEffect of Denosumab on Cellular Biomarkers in the Human Breast | jul 2014 (real) |
| Completado | Fase 2 | BlinatumomabClinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) | jul 2014 (real) |
| Completado | Fase 3 | Carfilzomib · FOCUSMieloma multiple | jul 2014 (real) |
| Completado | Fase 3 | DexamethasoneStudy Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma | jun 2014 (real) |
| Completado | Fase 3 | PanitumumabCancer colorrectal metastasico | jun 2014 (real) |
| Completado | no aplica | EtanerceptOrganization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project | jun 2014 (real) |
| Completado | Fase 1 | AMG 811Nefritis · Lupus eritematoso sistemico | jun 2014 (real) |
| Completado | Fase 3 | Atorvastatin · AMG145Hiperlipidemía o dislipidemia mixta con alto riesgo de eventos cardiovasculares | jun 2014 (real) |
| Completado | Fase 3 | EtelcalcetideEfficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis | may 2014 (real) |
| Interrumpido | Fase 3 | cinacalcet capsuleEnfermedad renal cronica · Hiperparatiroidismo · Hiperparatiroidismo secundario · Enfermedad renal · Hiperparatiroidismo secundario | abr 2014 (real) |
| Completado | Fase 1 | [¹⁴C]EtelcalcetidePharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis | abr 2014 (real) |
| Completado | Fase 3 | EtelcalcetideEfficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis | abr 2014 (real) |
| Completado | no aplica | Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis | abr 2014 (real) |
| Completado | Fase 1 | AMG 181Colitis ulcerosa · Enfermedad de Crohn | abr 2014 (real) |
| Completado | Fase 1 | ErenumabStudy of Erenumab (AMG 334) in Women With Hot Flashes | mar 2014 (real) |
| Completado | Fase 4 | Etanercept via Autoinjector AArtritis reumatoide · Psoriasis en placas | mar 2014 (real) |
| Interrumpido | Fase 3 | Darbepoetin AlfaStudy to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease | mar 2014 (real) |
| Completado | no aplica | Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia PatientsLeucemia linfoblastica aguda | mar 2014 (real) |
| Completado | Fase 1 | AMG 386 30 mgSafety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer | feb 2014 (real) |
| Completado | Fase 3 | Apremilast tablet 20 mg · POSTUREStudy of Apremilast to Treat Subjects With Active Ankylosing Spondylitis | feb 2014 (real) |
| Completado | Fase 1 | RomosozumabOsteoporosis | feb 2014 (real) |
| Completado | Fase 2 | Blinatumomab · BLASTConfirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL) | feb 2014 (real) |
| Completado | Fase 2/3 | Evolocumab · TESLATrial Evaluating PCSK9 Antibody in Subjects With LDL Receptor Abnormalities | ene 2014 (real) |
| Completado | Fase 3 | EtelcalcetideHiperparatiroidismo secundario | ene 2014 (real) |
| Completado | no aplica | Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic LeukemiaLeucemia linfoblastica aguda | ene 2014 (real) |
| Completado | Fase 4 | romiplostimStudy on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP) | ene 2014 (real) |
| Interrumpido | no aplica | AranespStudy of South African Dialysis Patients | ene 2014 (real) |
| Interrumpido | Fase 1 | AMG 761Asma | ene 2014 (real) |
| Completado | Fase 3 | EtanerceptStudy to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept | dic 2013 (real) |
| Completado | no aplica | Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy. | dic 2013 (real) |
| Interrumpido | Fase 1 | AMG 780Tumor solido avanzado | dic 2013 (real) |
| Completado | Fase 3 | Evolocumab · RUTHERFORD-2Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2 | nov 2013 (real) |
| Completado | Fase 3 | Evolocumab · GAUSS-2Hiperlipidemia | nov 2013 (real) |
| Completado | Fase 3 | Evolocumab AMDHipercolesterolemia primaria · Dislipidemia mixta | nov 2013 (real) |
| Completado | Fase 3 | Evolocumab · LAPLACE-2Hiperlipidemia | nov 2013 (real) |
| Completado | Fase 3 | Evolocumab · DESCARTESHipercolesterolemia | oct 2013 (real) |
| Completado | Fase 3 | Evolocumab · MENDEL-2Hiperlipidemia | oct 2013 (real) |
| Completado | Fase 2 | BlinatumomabLeucemia linfoblastica aguda | oct 2013 (real) |
| Completado | Fase 1 | AMG 319AMG 319 Lymphoid Malignancy FIH | oct 2013 (real) |
| Completado | Fase 2 | RomiplostimInterventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim | sep 2013 (real) |
| Completado | Fase 3 | Evolocumab Pre-filled SyringeHipercolesterolemia primaria · Dislipidemia mixta | sep 2013 (real) |
| Completado | Fase 1 | DenosumabVoluntarios sanos | sep 2013 (real) |
| Completado | no aplica | Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia | ago 2013 (real) |
| Completado | Fase 1 | RilotumumabPhase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ | ago 2013 (real) |
| Completado | Fase 1 | AMG 386Tumor solido avanzado | ago 2013 (real) |
| Interrumpido | Fase 2 | AMG 747Esquizofrenia | jun 2013 (real) |
| Completado | no aplica | TRANSFORMAnemia | jun 2013 (real) |
| Interrumpido | Fase 2 | AMG 747Esquizofrenia | jun 2013 (real) |
| Completado | Fase 2 | Evolocumab · AMG145A Study to Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese Subjects | may 2013 (real) |
| Completado | Fase 1 | CarfilzomibPhase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma | may 2013 (real) |
| Interrumpido | Fase 1 | AMG 557 or PLACEBOPsoriasis | may 2013 (real) |
| Completado | Fase 1 | TezepelumabAsma | abr 2013 (real) |
| Completado | Fase 1 | ErenumabAscending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients | mar 2013 (real) |
| Interrumpido | Fase 4 | PeginesatideAnemia | mar 2013 (real) |
| Interrumpido | Fase 1 | AMG 557Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus | mar 2013 (real) |
| Completado | Fase 3 | AMG 386Cancer de trompa de Falopio · Cancer de ovario · Carcinoma peritoneal primario | mar 2013 (real) |
| Completado | Fase 1 | AMG 386 + PaclitaxelA Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function | feb 2013 (real) |
| Completado | Fase 3 | Apremilast 20mg · PALACE4artritis psoriasica | feb 2013 (real) |
| Completado | Fase 3 | CetuximabCancer colorrectal metastasico | feb 2013 (real) |
| Completado | Fase 2 | CCX140-BA Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria | feb 2013 (real) |
| Completado | no aplica | European Union Registry in Paediatric Chronic Kidney Disease Patients Looking at Safety and Usage Patterns of Darbepoetin AlfaEnfermedad renal cronica | feb 2013 (real) |
| Completado | Fase 3 | HPN-100Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs) | feb 2013 (real) |
| Completado | Fase 4 | etanerceptArtritis reumatoide | feb 2013 (real) |
| Completado | Fase 1 | AMG 208Cancer · Oncologia · Tumores · Neoplasia maligna avanzada · Tumores solidos avanzados · Pacientes oncologicos | feb 2013 (real) |
| Completado | Fase 2 | CC-11050To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus | ene 2013 (real) |
| Interrumpido | Fase 1 | Amg 181Colitis ulcerosa | ene 2013 (real) |
| Interrumpido | Fase 1 | AMG 151Diabetes | ene 2013 (real) |
| Completado | Fase 2 | carfilzomibMieloma multiple | ene 2013 (real) |
| Completado | Fase 1 | DenosumabInsuficiencia renal | ene 2013 (real) |
| Completado | no aplica | EtanerceptPsoriasis | dic 2012 (real) |
| Completado | Fase 4 | EtanerceptArtritis reumatoide | dic 2012 (real) |
| Completado | Fase 3 | etanercept · REFINEPsoriasis | dic 2012 (real) |
| Completado | Fase 1 | RomosozumabOsteoporosis | nov 2012 (real) |
| Completado | Fase 1 | OprozomibTumor solido | nov 2012 (real) |
| Completado | Fase 3 | Darbepoetin alfaInsuficiencia cardiaca · Anemia · Enfermedad cardiovascular · Disfuncion ventricular · Insuficiencia cardiaca congestiva | oct 2012 (real) |
| Completado | Fase 2 | AMG 151Diabetes | oct 2012 (real) |
| Completado | Fase 1 | AMG 386Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer | oct 2012 (real) |
| Completado | Fase 3 | MP-376 · TISFibrosis quistica | oct 2012 (real) |
| Completado | Fase 1 | AMG 811 or PlaceboPsoriasis | oct 2012 (real) |
| Completado | Fase 3 | PegfilgrastimPAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study | sep 2012 (real) |
| Completado | Fase 2 | denosumabStudy of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium | sep 2012 (real) |
| Completado | Fase 3 | CinacalcetTreatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients | sep 2012 (real) |
| Interrumpido | Fase 1 | AMG811Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus | sep 2012 (real) |
| Completado | no aplica | STEPPS™Enfermedad renal cronica | sep 2012 (real) |
| Completado | Fase 3 | Apremilast 20mg · PALACE 3Artritis psoriasica | ago 2012 (real) |
| Completado | Fase 3 | Apremilast 20mg · PALACE2artritis psoriasica | jul 2012 (real) |
| Completado | Fase 4 | Traditional Vitamin D TherapyHiperparatiroidismo secundario | jul 2012 (real) |
| Completado | Fase 3 | CinacalcetHiperparatiroidismo primario · Hipercalcemia | jul 2012 (real) |
| Interrumpido | Fase 2 | AMG 706Tumor solido | jul 2012 (real) |
| Interrumpido | Fase 1 | AMG 876Diabetes mellitus | jul 2012 (real) |
| Completado | Fase 2 | Romosozumab · STARTT-HipStudy To Assess FRacTure Healing With SclerosTin Antibody - Hip | jun 2012 (real) |
| Completado | Fase 2 | CisplatinPARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response | jun 2012 (real) |
| Retirado antes de empezar | Fase 1 | AMG 827 or PlaceboAsma | jun 2012 (real) |
| Interrumpido | Fase 1 | AMG 579Esquizofrenia | jun 2012 (real) |
| Completado | Fase 2 | PanitumumabPEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors | may 2012 (real) |
| Completado | Fase 2 | Evolocumab · RUTHERFORDHipercolesterolemia familiar | may 2012 (real) |
| Completado | Fase 2 | PanitumumabCancer · Cancer de colon · Cancer colorrectal · Cancer metastasico · Cancer de recto · Cancer colorrectal metastasico | may 2012 (real) |
| Completado | Fase 2 | Evolocumab · GAUSSGoal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects | may 2012 (real) |
| Completado | Fase 3 | AeroquinFibrosis quistica | may 2012 (real) |
| Completado | Fase 3 | DenosumabExtension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer | may 2012 (real) |
| Completado | Fase 2 | ApremilastA Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease | may 2012 (real) |
| Completado | Fase 1 | AMG 557Lupus eritematoso sistemico | may 2012 (real) |
| Completado | Fase 3 | Apremilast 20mg · PALACE-1Artritis psoriasica | abr 2012 (real) |
| Completado | Fase 3 | Cinacalcet · EVOLVEE.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events | abr 2012 (real) |
| Completado | Fase 2 | Evolocumab · LAPLACELAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy | abr 2012 (real) |
| Completado | Fase 1 | ApremilastVoluntarios sanos | abr 2012 (real) |
| Completado | Fase 2 | HPN-100 · HALT-HEA Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy | abr 2012 (real) |
| Completado | Fase 3 | darbepoetin alfaAnemia · Enfermedad renal cronica | abr 2012 (real) |
| Completado | Fase 3 | Apremilast · ESTEEM 2Psoriasis en placas | mar 2012 (real) |
| Completado | Fase 2 | Romosozumab · STARTTStudy of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing | mar 2012 (real) |
| Completado | Fase 2 | Evolocumab · MENDELMonoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels | mar 2012 (real) |
| Completado | Fase 1 | ApremilastVoluntarios sanos | mar 2012 (real) |
| Completado | Fase 2 | BlinatumomabStudy of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL) | mar 2012 (real) |
| Completado | Fase 3 | Apremilast · ESTEEM 1Psoriasis en placas | feb 2012 (real) |
| Interrumpido | Fase 2 | Apremilast 30 mgArtritis reumatoide | feb 2012 (real) |
| Completado | Fase 1 | AMG 167An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density | feb 2012 (real) |
| Completado | Fase 3 | amg 162Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only | feb 2012 (real) |
| Completado | Fase 1 | A1: AMG 386 10 mgAMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR | ene 2012 (real) |
| Completado | Fase 2 | AMG 827Asma | dic 2011 (real) |
| Completado | Fase 3 | Actonel®Osteoporosis | dic 2011 (real) |
| Completado | Fase 3 | EtanerceptPsoriasis en placas pediatrica | dic 2011 (real) |
| Completado | no aplica | CinacalcetPRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice | dic 2011 (real) |
| Completado | Fase 2 | PanitumumabRadiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck | dic 2011 (real) |
| Interrumpido | Fase 2 | BrodalumabEnfermedad de Crohn | oct 2011 (real) |
| Interrumpido | Fase 2 | BrodalumabEnfermedad de Crohn | oct 2011 (real) |
| Completado | Fase 2 | AMG 386Carcinoma hepatocelular avanzado · Carcinoma hepatocelular inoperable | oct 2011 (real) |
| Completado | Fase 3 | 1=EtanerceptPsoriasis | oct 2011 (real) |
| Completado | Fase 1 | EvolocumabAscending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Evolocumab (AMG 145) in Adults With Hyperlipidemia on Stable Doses of a Statin | sep 2011 (real) |
| Completado | Fase 1 | AMG 557Lupus eritematoso sistemico | sep 2011 (real) |
| Completado | Fase 3 | HPN-100Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD) | sep 2011 (real) |
| Completado | Fase 2 | SunitinibAMG 386 Phase 2 Open-Label Renal Cell Carcinoma (RCC) Study 1st Line or After Cytokine Failure in Combination With Sunitinib | ago 2011 (real) |
| Completado | Fase 1 | BlinatumomabSafety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL | ago 2011 (real) |
| Completado | Sin fase asignada | RomiplostimEvaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS) | jul 2011 (real) |
| Completado | Fase 3 | HZT-501Osteoartritis · Artritis reumatoide · Dolor lumbar cronico · Sindrome de dolor regional cronico · Dolor cronico de tejidos blandos | jul 2011 (real) |
| Completado | Fase 1 | DenosumabThe Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam | jul 2011 (real) |
| Completado | Fase 2 | CCX-354-C · CARAT-2Artritis reumatoide | jul 2011 (real) |
| Completado | Fase 2 | Adecatumumab · MT201-204Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases | jul 2011 (real) |
| Completado | Fase 3 | Cystagon®Cistinosis | jun 2011 (real) |
| Retirado antes de empezar | Fase 2 | AMG 745 0.3 mgPerdida muscular asociada a la edad | may 2011 (prevista, ya pasada: sin actualizar en el registro) |
| Completado | Fase 2 | Sensipar · BONAFIDEBone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease | may 2011 (real) |
| Interrumpido | Fase 2 | AMG 827Artritis reumatoide | abr 2011 (real) |
| Completado | Fase 2 | RomiplostimRomiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) | mar 2011 (real) |
| Completado | Fase 2 | CisplatinStudy of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer | mar 2011 (real) |
| Completado | Fase 3 | AMG 162An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density | mar 2011 (real) |
| Completado | Fase 1/2 | AMG 655Cancer de pulmon no microcitico | mar 2011 (real) |
| Interrumpido | Fase 3 | AMG 706Cancer de pulmon no microcitico | mar 2011 (real) |
| Completado | Fase 2 | AlendronateBaja densidad mineral osea · Osteoporosis posmenopausica | feb 2011 (real) |
| Completado | Fase 2 | BrodalumabArtritis reumatoide | feb 2011 (real) |
| Completado | Fase 1 | TezepelumabVoluntarios sanos | ene 2011 (real) |
| Completado | Fase 1 | TezepelumabDermatitis atopica · Voluntarios sanos | ene 2011 (real) |
| Completado | Fase 3 | RomiplostimAn Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP | ene 2011 (real) |
| Completado | Fase 1/2 | AMG 102AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer | ene 2011 (real) |
| Completado | Fase 1 | AMG 853Asma | ene 2011 (real) |
| Completado | Fase 2 | PanitumumabCancer · Carcinoma · Cancer de cabeza y cuello · Metastasis · Cancer metastasico · Carcinoma de celulas escamosas metastasico o recurrente de cabeza y cuello · Oncologia · Carcinoma de celulas escamosas · Tumores | dic 2010 (real) |
| Completado | Fase 4 | Cinacalcet20070360 Incident Dialysis | dic 2010 (real) |
| Completado | Fase 3 | MethotrexatePsoriasis | dic 2010 (real) |
| Completado | Fase 2 | AMG 853Asma | dic 2010 (real) |
| Completado | Fase 1 | RomosozumabA Single-dose Study Evaluating Romosozumab (AMG 785) in Healthy Postmenopausal Japanese and Non-Japanese Women | nov 2010 (real) |
| Completado | Fase 1/2 | CapecitabineAMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer | nov 2010 (real) |
| Completado | Fase 2 | carfilzomibMieloma multiple | nov 2010 (real) |
| Completado | Fase 1 | AMG 706Tumor solido avanzado | nov 2010 (real) |
| Completado | Fase 2 | pioglitazoneDiabetes tipo 2 | oct 2010 (real) |
| Completado | Fase 1 | CCX168A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants | sep 2010 (real) |
| Completado | Fase 1 | HPN-100Double-Blind Randomized Crossover Trial to Access Electrocardiogram Effects of HPN-100 | sep 2010 (real) |
| Completado | Fase 2 | AMG 386A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma | sep 2010 (real) |
| Completado | Fase 3 | HPN-100Trastornos del ciclo de la urea | sep 2010 (real) |
| Completado | Fase 1 | RomosozumabA Study to Evaluate the Effect of Romosozumab (AMG 785) on Bone Quality of the Forearm in Postmenopausal Women With Low Bone Mass | ago 2010 (real) |
| Completado | Fase 1 | AMG 853Voluntarios sanos | ago 2010 (real) |
| Completado | Fase 2 | AMG 386 PlaceboPhase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients | ago 2010 (real) |
| Completado | Fase 1/2 | AMG 655Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer | ago 2010 (real) |
| Completado | Fase 3 | DenosumabCancer de Prostata Refractario a Hormonas | jul 2010 (real) |
| Completado | Fase 1 | AMG 655Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat | jul 2010 (real) |
| Completado | Fase 1/2 | CCX 354-C · CARAT-1Artritis reumatoide | jul 2010 (real) |
| Completado | Fase 3 | DenosumabA High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab | jun 2010 (real) |
| Completado | Fase 2 | Previous denosumabA Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab | jun 2010 (real) |
| Completado | Fase 1/2 | BrodalumabArtritis reumatoide | may 2010 (real) |
| Completado | Fase 3 | ARM 2 · SPECTRUMCancer de cabeza y cuello recurrente y/o metastatico | may 2010 (real) |
| Completado | Fase 2 | AMG 386AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib | abr 2010 (real) |
| Completado | Fase 1 | ganitumabLinfoma · Cancer de prostata · Sarcoma · Cancer de intestino delgado · Tumor solido en adultos no especificado, protocolo especifico | abr 2010 (real) |
| Completado | Fase 1 | FOLFOX-4Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer | abr 2010 (real) |
| Completado | Fase 2 | Lodotra · MONAAsma | mar 2010 (real) |
| Completado | Fase 1 | AMG 811Lupus eritematoso sistemico | mar 2010 (real) |
| Completado | Fase 3 | RomiplostimOpen Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | ene 2010 (real) |
| Completado | Fase 4 | EtanerceptPsoriasis | ene 2010 (real) |
| Completado | Fase 2 | MP-376EPOC | ene 2010 (real) |
| Completado | Fase 1 | MP-376Fibrosis quistica | dic 2009 (real) |
| Completado | Fase 1 | AMG 167Osteopenia | nov 2009 (real) |
| Completado | Fase 2 | AMG 531Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents | oct 2009 (real) |
| Completado | Fase 3 | zoledronic acidMetastasis oseas | oct 2009 (real) |
| Completado | Fase 1/2 | Cystagon®Cistinosis | oct 2009 (real) |
| Completado | Fase 1 | CarfilzomibSafety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies | oct 2009 (real) |
| Completado | no aplica | A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic ChemotherapyCancer de mama · Cancer de pulmon no microcitico · Cancer de ovario · Cancer de pulmon microcitico | oct 2009 (real) |
| Completado | Fase 2 | BlinatumomabLeucemia linfoblastica aguda | sep 2009 (real) |
| Completado | Fase 2 | AMG 386Cancer de ovario · Cancer de trompa de Falopio · Carcinoma peritoneal primario | ago 2009 (real) |
| Completado | Fase 3 | PanitumumabCancer colorrectal metastasico | ago 2009 (real) |
| Completado | Fase 2 | Apremilast 10mgEfficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study) | ago 2009 (real) |
| Completado | Fase 1/2 | AMG 655Sarcoma de tejidos blandos localmente avanzado o metastasico, irresecable · Sarcoma · Sarcoma de tejidos blandos | ago 2009 (real) |
| Completado | Fase 3 | DenosumabMetastasis oseas | jul 2009 (real) |
| Completado | Fase 4 | etanerceptPsoriasis | jul 2009 (real) |
| Completado | Fase 3 | alendronateOsteoporosis | jun 2009 (real) |
| Completado | Fase 2 | PanitumumabCancer colorrectal metastasico | jun 2009 (real) |
| Retirado antes de empezar | Fase 2 | AMG 108Diabetes | jun 2009 (prevista, ya pasada: sin actualizar en el registro) |
| Completado | Fase 2 | MP-376Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients | jun 2009 (real) |
| Completado | Fase 4 | CinacalcetA Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD) | jun 2009 (real) |
| Completado | Fase 2 | ApremilastArtritis psoriasica | may 2009 (real) |
| Completado | Fase 1/2 | PanitumumabConatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study | may 2009 (real) |
| Completado | Fase 3 | MR prednisone · CAPRA-2Artritis reumatoide | may 2009 (real) |
| Completado | Fase 4 | cinacalcetEnfermedad renal cronica · Enfermedad renal terminal · Calcificacion de la arteria coronaria · Calcificacion vascular · Calcificacion · Enfermedad cardiovascular · Insuficiencia renal cronica · Hiperparatiroidismo · Enfermedad renal · Nefrologia · Hiperparatiroidismo secundario | may 2009 (real) |
| Completado | Fase 3 | PanitumumabCancer colorrectal metastasico | abr 2009 (real) |
| Completado | Fase 3 | DenosumabStudy of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma. | abr 2009 (real) |
| Completado | Fase 2 | ApremilastApremilast Safety and PK Study in Recalcitrant Plaque Psoriasis | abr 2009 (real) |
| Completado | Fase 1 | DocetaxelPhase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer | abr 2009 (real) |
| Interrumpido | Fase 2 | Gemcitabine · APPRISE 1Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint | abr 2009 (real) |
| Completado | Fase 3 | Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT) | mar 2009 (real) |
| Completado | Fase 2 | AMG 102 at 10 mgCarcinoma de celulas renales avanzado | mar 2009 (real) |
| Completado | Fase 1/2 | AMG 531Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects | mar 2009 (real) |
| Completado | Fase 1 | PanitumumabCancer colorrectal metastasico | mar 2009 (real) |
| Completado | Fase 2 | AMG 531A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid | mar 2009 (real) |
| Completado | Fase 2 | AMG 951Cancer de pulmon no microcitico | mar 2009 (real) |
| Completado | Fase 3 | AMG 162Osteoporosis posmenopausica | feb 2009 (real) |
| Completado | Fase 1 | RomosozumabA Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785) | dic 2008 (real) |
| Completado | Fase 2 | AMG 102 at 20 mgA Phase II Study to Treat Advanced Malignant Glioma | dic 2008 (real) |
| Completado | Fase 2 | RomiplostimDose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) | dic 2008 (real) |
| Completado | no aplica | IMPACT Non Hodgkins Lymphoma (NHL) StudyLinfoma no Hodgkin | dic 2008 (real) |
| Completado | Fase 3 | EtanerceptArtritis reumatoide | dic 2008 (real) |
| Interrumpido | Fase 3 | Darbepoetin alfaAnemia · Enfermedad renal cronica | dic 2008 (real) |
| Completado | Fase 1 | AMG 706Tumor solido | dic 2008 (real) |
| Completado | Fase 3 | Etanerceptartritis reumatoide | dic 2008 (real) |
| Completado | Fase 2 | AMG 714Psoriasis | dic 2008 (real) |
| Completado | Fase 3 | Medical Standard of Care for ITPRomiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura | nov 2008 (real) |
| Completado | Fase 2 | AMG 223Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia | nov 2008 (real) |
| Completado | Fase 3 | PanitumumabEvaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer | oct 2008 (real) |
| Completado | Fase 3 | HZT-501 · HZ-CA-304Artrosis · Artritis reumatoide · Dolor lumbar cronico · Sindrome de dolor regional cronico · Dolor cronico de tejidos blandos | oct 2008 (real) |
| Completado | Fase 1 | MP-376EPOC | oct 2008 (real) |
| Completado | Fase 2 | AMG 317 75 mgAsma | sep 2008 (real) |
| Interrumpido | Fase 2 | sodium phenylacetate and sodium…Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy | sep 2008 (real) |
| Completado | Fase 3 | HZT-501Ulcera peptica | sep 2008 (real) |
| Completado | Fase 3 | IbuprofenEfficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment | ago 2008 (real) |
| Completado | Fase 1 | AMG 223Voluntarios sanos | ago 2008 (real) |
| Completado | Fase 2 | CCX282-BEnfermedad de Crohn | ago 2008 (real) |
| Completado | Fase 2 | HPN-100Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders | jul 2008 (real) |
| Completado | Fase 3 | DenosumabOsteoporosis | jun 2008 (real) |
| Completado | no aplica | Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | jun 2008 (real) |
| Completado | no aplica | ENBREL®Artritis reumatoide | jun 2008 (real) |
| Completado | Fase 2 | AMG 108Artritis reumatoide | jun 2008 (real) |
| Completado | Fase 2 | AntizolPhase IIa Study of Fomepizole for Acetaldehyde Toxicity After Ethanol Exposure in Subjects With Altered Ethanol Metabolism | jun 2008 (real) |
| Completado | no aplica | LEARN-6™: A Prospective, Observational Nursing Home StudyAnemia · Enfermedad renal cronica | jun 2008 (real) |
| Completado | Fase 2 | CCX282-BA Phase II Study of CCX282-B in Patients With Celiac Disease | jun 2008 (real) |
| Completado | Fase 3 | AMG 162Cancer de prostata | may 2008 (real) |
| Completado | Fase 1/2 | AMG 531A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma | may 2008 (real) |
| Completado | Fase 2 | RomiplostimDetermination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS) | may 2008 (real) |
| Interrumpido | Fase 2 | BevacizumabA Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC | abr 2008 (real) |
| Completado | Fase 2 | DenosumabSafety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone | abr 2008 (real) |
| Completado | Fase 1 | AMG 706A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid Tumors | abr 2008 (real) |
| Completado | Fase 3 | alendronateStudy of Transitioning From Alendronate to Denosumab | mar 2008 (real) |
| Completado | Fase 3 | denosumabDensidad mineral osea baja · Osteopenia · Osteoporosis | mar 2008 (real) |
| Completado | Fase 2 | AlendronateA Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density | mar 2008 (real) |
| Completado | Fase 2 | IrinotecanCancer colorrectal | feb 2008 (real) |
| Completado | Fase 1 | AMG 403Artrosis | ene 2008 (real) |
| Completado | Fase 2 | AMG 162 180 mgStudy of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates | ene 2008 (real) |
| Completado | Fase 2 | Panitumumab · STEPPSkin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy | ene 2008 (real) |
| Completado | no aplica | Enbrel®Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis | ene 2008 (real) |
| Completado | Fase 2 | darbepoetin alfaDarbepoetin Alfa With or Without Intravenous (IV) Iron | dic 2007 (real) |
| Completado | no aplica | DMARDArtritis reumatoide | dic 2007 (real) |
| Completado | Fase 2/3 | paliferminCancer de colon | dic 2007 (real) |
| Completado | Fase 1 | MP-376Fibrosis quistica | dic 2007 (real) |
| Completado | Fase 2 | AMG 108Artritis reumatoide | nov 2007 (real) |
| Completado | Fase 3 | AlendronateOsteoporosis · Osteopenia | nov 2007 (real) |
| Completado | Fase 3 | PaliferminCancer de cabeza y cuello | nov 2007 (real) |
| Interrumpido | Fase 3 | Darbepoetin alfaAnemia · enfermedad cardiovascular · insuficiencia cardiaca congestiva · insuficiencia cardiaca · disfuncion ventricular | oct 2007 (real) |
| Completado | Fase 2 | PanitumumabStudy for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment | sep 2007 (real) |
| Completado | no aplica | Ancillary Study to Protocol 20060104Artritis reumatoide | ago 2007 (real) |
| Completado | Fase 2 | DENOSUMABMieloma multiple en recaida o en fase de plateau | ago 2007 (real) |
| Completado | Fase 1 | AMG 623Lupus eritematoso sistemico | ago 2007 (real) |
| Completado | Fase 3 | EtanerceptArtritis reumatoide | ago 2007 (real) |
| Completado | Fase 1 | RomosozumabA First-in-human Study Evaluating Romosozumab (AMG 785) in Healthy Men and Postmenopausal Women | jul 2007 (real) |
| Interrumpido | Fase 1 | AMG 706Cancer de pulmon · Cancer de pancreas · Cancer de esofago | jun 2007 (real) |
| Completado | Fase 2 | NeulastaCancer de mama | jun 2007 (real) |
| Completado | Fase 2 | 100 mg AMG 162Osteoporosis | jun 2007 (real) |
| Completado | Fase 3 | Oxaliplatin Based ChemotherapyCancer colorrectal | may 2007 (real) |
| Completado | Fase 3 | AMG 162AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer | may 2007 (real) |
| Completado | no aplica | filgrastimOpen-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors | may 2007 (real) |
| Completado | Fase 2 | PanitumumabCancer colorrectal · Cancer metastasico | may 2007 (real) |
| Completado | Fase 2 | denosumabArtritis reumatoide | abr 2007 (real) |
| Completado | Fase 2 | DenosumabDetermine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density | abr 2007 (real) |
| Completado | Fase 1 | AMG 623Lupus eritematoso sistemico | abr 2007 (real) |
| Interrumpido | Fase 3 | Epoetin alfa DTEnfermedad renal crónica | mar 2007 (real) |
| Completado | Fase 1/2 | PanitumumabCancer de pulmon no microcitico | mar 2007 (real) |
| Completado | Fase 2 | CC-10004 · PSOR-003Psoriasis | feb 2007 (real) |
| Completado | Fase 3 | Epoetin alfa DTEnfermedad renal cronica | feb 2007 (real) |
| Completado | Fase 2 | AMG 706Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors | feb 2007 (real) |
| Completado | Fase 2 | PanitumumabCancer colorrectal · Metastasis | ene 2007 (real) |
| Completado | Fase 3 | darbepoetin alfa SFStudy to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease | ene 2007 (real) |
| Completado | Fase 2 | Darbepoetin alfaFractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies | ene 2007 (real) |
| Completado | Fase 2 | pegfilgrastimPegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy | ene 2007 (real) |
| Completado | Fase 3 | Darbepoetin AlfaEnfermedad renal cronica | ene 2007 (real) |
| Completado | Fase 3 | Epoetin alfa RBNefrologia | ene 2007 (real) |
| Completado | Fase 3 | A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 StudyAnemia · Cancer | ene 2007 (real) |
| Completado | Fase 3 | AMG 531AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy | dic 2006 (real) |
| Completado | Fase 3 | 50 mg EtanerceptArtritis reumatoide | dic 2006 (real) |
| Completado | no aplica | Safety observationA Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson's Disease Previously Treated With Intraputaminal Infusion of Liatermin | nov 2006 (real) |
| Completado | Fase 2 | AMG 706Cancer de tiroides | nov 2006 (real) |
| Completado | Fase 3 | Darbepoetin AlfaAnemia · Cancer | oct 2006 (real) |
| Completado | Fase 4 | Sensipar®Hiperparatiroidismo secundario | oct 2006 (real) |
| Completado | Fase 3 | AMG 531AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy | sep 2006 (real) |
| Completado | Fase 3 | Etanercept16.0040 Ankylosing Spondylitis Study | ago 2006 (real) |
| Completado | Fase 2 | AMG 706Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) | jun 2006 (real) |
| Completado | Fase 2 | PegfilgrastimChemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer | may 2006 (real) |
| Completado | Fase 1 | panitumumabTwo Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors | abr 2006 (real) |
| Completado | Fase 4 | EtanerceptArtritis reumatoide | mar 2006 (real) |
| Completado | Fase 3 | EtanerceptPsoriasis | feb 2006 (real) |
| Completado | Fase 1 | Anti-angiogenesisStudy Evaluating AMG 706 in Subjects With Advanced Solid Tumors | feb 2006 (real) |
| Completado | Fase 4 | NB-UVBPsoriasis | feb 2006 (real) |
| Completado | Fase 1 | AMG 403A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 403 in Healthy Subject | ene 2006 (real) |
| Completado | Fase 4 | FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy | dic 2005 (real) |
| Completado | Fase 3 | Darbepoetin AlfaStudy Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis | nov 2005 (real) |
| Completado | Fase 1/2 | LiaterminEnfermedad de Parkinson | nov 2005 (real) |
| Completado | Fase 3 | cinacalcetSENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism | nov 2005 (real) |
| Completado | Fase 3 | Darbepoetin AlfaTreatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis | nov 2005 (real) |
| Completado | Fase 2 | DenosumabDenosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer | nov 2005 (real) |
| Completado | Fase 2 | CC10004 · PSOR-001Psoriasis | oct 2005 (real) |
| Completado | Fase 3 | Darbepoetin AlfaAnemia · Enfermedad renal | oct 2005 (real) |
| Completado | Fase 4 | EtanerceptREPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®) | ago 2005 (real) |
| Completado | Fase 2 | pegfilgrastimLinfoma no Hodgkin | ago 2005 (real) |
| Completado | Fase 3 | Etanerceptpsoriasis | jul 2005 (real) |
| Completado | Fase 2 | Systemic AMG 108Artrosis | jun 2005 (real) |
| Completado | Fase 2 | cinacalcetA Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism | jun 2005 (real) |
| Completado | Fase 2 | Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian CancerCancer de ovario | abr 2005 (real) |
| Completado | Fase 4 | cinacalcetEnfermedad renal terminal | abr 2005 (real) |
| Completado | Fase 3 | Darbepoetin alfaAnemia · Neoplasias malignas no mieloides | mar 2005 (real) |
| Completado | Fase 3 | De Novo Administration of…enfermedad renal cronica · enfermedad renal | mar 2005 (real) |
| Completado | Fase 2 | Intra-articular metHuIL-1raArtrosis | feb 2005 (real) |
| Completado | Fase 1 | Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal WomenOsteoporosis | dic 2004 (real) |
| Completado | Fase 3 | Darbepoetin alfaAnemia · neoplasias no mieloides | dic 2004 (real) |
| Completado | Fase 2 | ABX-EGFABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) | dic 2004 (real) |
| Completado | Fase 3 | darbepoetin alfaNESP Pediatric Study | nov 2004 (real) |
| Completado | Fase 4 | NeulastaA Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer | nov 2004 (real) |
| Completado | Fase 1 | etanerceptOpen-label Study Using 50 Mg Liquid Etanercept Subcutaneous Injection in the Thigh to Compare an Auto-injector Device and a Manual Injection in Healthy Subjects | oct 2004 (real) |
| Completado | no aplica | Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation | sep 2004 (real) |
| Completado | Fase 2 | carboplatinCancer de mama · Cancer de pulmon · Cancer de ovario | ago 2004 (real) |
| Completado | Fase 1/2 | RomiplostimAmgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP) | jul 2004 (real) |
| Completado | Fase 2 | RomiplostimEvaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP) | jun 2004 (real) |
| Interrumpido | Fase 3 | EtanerceptArtritis reumatoide juvenil | may 2004 (real) |
| Completado | Fase 2 | AMG 719Artritis reumatoide | may 2004 (real) |
| Completado | Fase 2 | filgrastimTrial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML) | abr 2004 (real) |
| Completado | Fase 4 | Darbepoetin alfaEnfermedad renal cronica · Insuficiencia renal cronica · Enfermedad renal · Prediálisis · Pre-ESRD | mar 2004 (real) |
| Completado | Fase 2 | pegfilgrastim 12 mgPegfilgrastim PBPC Mobilization Study | mar 2004 (real) |
| Completado | Fase 4 | Darbepoetin alfaSTAAR-2 Clinical Study | mar 2004 (real) |
| Completado | Fase 4 | EnbrelArtritis reumatoide | feb 2004 (real) |
| Completado | Fase 3 | pegfilgrastimNeutropenia | feb 2004 (real) |
| Interrumpido | Fase 2 | darbepoetin alfaDarbepoetin Alfa and Anemia of Cancer | ene 2004 (real) |
| Completado | Fase 1 | Auto-injector deviceCompare Actions in Healthy Volunteer of 50 mg Etanercept Injection Using an Auto-injector Device and Manual Injection | ene 2004 (real) |
| Completado | Fase 2 | AnakinraJuvenile Rheumatoid Arthritis | nov 2003 (real) |
| Completado | Fase 3 | rHuEPOCancer · Neoplasias no mieloides | nov 2003 (real) |
| Completado | Fase 2 | darbepoetin alfaPhase 2 Study of Darbepoetin Alfa Extended Dosing | oct 2003 (real) |
| Completado | Fase 3 | Darbepoetin alfaNeoplasias · Anemia | oct 2003 (real) |
| Completado | Fase 2 | AMG 07312-month Study of AMG 073 in Renal Osteodystrophy | ago 2003 (real) |
| Completado | Fase 3 | AMG 073Hiperparatiroidismo secundario · Enfermedad renal en etapa terminal | jul 2003 (real) |
| Completado | Fase 2 | darbepoetin alfaStudy to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa | jun 2003 (real) |
| Completado | Fase 3 | AMG 073Hiperparatiroidismo | abr 2003 (real) |
| Completado | Fase 3 | AMG 073A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients | mar 2003 (real) |
| Interrumpido | Fase 2 | anakinraArtritis reumatoide | mar 2003 (real) |
| Completado | Fase 2 | Darbepoetin alfa SCChemotherapy Related Anemia | dic 2002 (real) |
| Interrumpido | Fase 3 | EtanerceptEtanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis | jun 2002 (real) |
| Completado | Fase 3 | EtanerceptDouble-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis | jun 2002 (real) |
| Completado | Fase 1/2 | Novel Erythropoiesis…Anemia · Tumor solido | mar 2002 (real) |
| Completado | Fase 2 | darbepoetin alfaFixed Dose NESP Study in Subjects With CRI | feb 2002 (real) |
| Completado | Fase 2 | cinacalcetA Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT) | mar 2001 (real) |
| Completado | Fase 2 | CinacalcetSafety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT) | dic 2000 (real) |
| Completado | Fase 3 | Darbepoetin alfaAnemia | nov 2000 (real) |
| Completado | Fase 2 | CinacalcetSafety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism | dic 1999 (real) |
| Completado | Fase 2/3 | Etanerceptartritis reumatoide juvenil | jul 1998 (real) |
| Sin noticias del promotor | Fase 2 | filgrastimCancer de vejiga · Cancer de celulas transicionales de la pelvis renal y el ureter | sin fecha |
| Completado | Fase 3 | Cinacalcet HClCinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis | sin fecha |
| Completado | Fase 1 | LiaterminStudy of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease | sin fecha |
| Completado | Fase 4 | AnakinraArtritis reumatoide | sin fecha |
| Completado | Fase 2 | Darbepoetin AlfaInsuficiencia cardiaca · Anemia | sin fecha |
| Completado | Fase 2 | darbepoetin alfaCancer de pulmon no microcitico · Anemia | sin fecha |
| Completado | Sin fase asignada | FilgrastimA Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex | sin fecha |
| Aprobado para comercializar | no aplica | UPLIZNAAMG 335 Expanded Access Program for IgG4-Related Disease | sin fecha |
| Completado | Fase 2 | Darbepoetin AlfaCancer de mama · Anemia | sin fecha |
| Ya no disponible | no aplica | AMG 701AMG 701 Expanded Access Program | sin fecha |
| Completado | Fase 2 | darbepoetin alfaTreatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy | sin fecha |
| Ya no disponible | no aplica | CC-10004Expanded Access for CC-10004 | sin fecha |
| Ya no disponible | no aplica | Talimogene LaherparepvecExpanded Access Study of Talimogene Laherparepvec for Treatment of Subjects With Unresected Stage IIIB-IVM1c Melanoma | sin fecha |
| Completado | Fase 4 | EtanerceptArtritis reumatoide | sin fecha |
| Completado | Fase 2 | Aranesp®Anemia · Cancer | sin fecha |
| Completado | Fase 4 | Aranesp®Study to Evaluate Effectiveness of Aranesp® | sin fecha |
| Aprobado para comercializar | no aplica | TarlatamabCancer de pulmon microcitico | sin fecha |
| Completado | Fase 2 | Darbepoetin AlfaSubcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia | sin fecha |
| Completado | Fase 2 | Darbepoetin alfaEvaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy | sin fecha |
| Completado | Fase 2 | darbepoetin alfaChemotherapy Related Anemia in Patients With Non-Myeloid Malignancies | sin fecha |
| Ya no disponible | no aplica | Talimogene LaherparepvecExpanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma | sin fecha |
| Aprobado para comercializar | no aplica | Teprotumumab · EAPExpanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease | sin fecha |
| Completado | Fase 3 | Aranesp®An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD) | sin fecha |
| Completado | Sin fase asignada | Interferon gamma-1bInfeccion por VIH | sin fecha |
| Completado | Fase 4 | AranespAnemia | sin fecha |
| Completado | Fase 3 | EtanerceptPsoriasis | sin fecha |
| Completado | Fase 2 | ABX-EGFABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) | sin fecha |
| Completado | Fase 2 | PegsunerceptArtritis reumatoide | sin fecha |
| Completado | Fase 4 | Aranesp®Anemia | sin fecha |
| Sin noticias del promotor | Fase 2 | filgrastimLinfoma | sin fecha |
| Completado | Sin fase asignada | TrifluridineEvaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study | sin fecha |
| Completado | Fase 3 | Darbepoetin alfa and Epoetin…Anemia | sin fecha |
| Sin noticias del promotor | Fase 2 | filgrastimDolor · Cancer de prostata | sin fecha |
| Completado | Fase 2 | pegfilgrastimSame Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) | sin fecha |
| Completado | Fase 2 | FilgrastimA Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection. | sin fecha |
| Completado | Fase 2 | AMG 714Artritis reumatoide | sin fecha |
| Completado | Fase 4 | AMG 073A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer | sin fecha |
| Completado | Fase 1 | SorafenibTumor solido avanzado | sin fecha |
| Completado | Fase 4 | Neulasta®Cancer de pulmon no microcitico | sin fecha |
| Completado | Fase 4 | SimpleJectTMArtritis reumatoide | sin fecha |
| Completado | Fase 3 | etanerceptInflamacion · Psoriasis | sin fecha |
| Completado | Fase 4 | EtanerceptArtritis reumatoide | sin fecha |
| Completado | Fase 2 | AMG 073Enfermedad renal terminal | sin fecha |
| Completado | Fase 4 | SensiparSTART: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism | sin fecha |
| Completado | Fase 2 | pegfilgrastimLinfoma no Hodgkin | sin fecha |
| Completado | Fase 2 | Darbepoetin AlfaAnemia | sin fecha |
| Completado | Fase 4 | Aranesp®Anemia · Neoplasias | sin fecha |
| Completado | Sin fase asignada | darbepoetin alfaImpact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia | sin fecha |
| Completado | Fase 2 | PanitumumabSafety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2 | sin fecha |
| Retirado antes de empezar | Fase 1 | AMG 954Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer | sin fecha |
| Completado | Fase 2 | CinacalcetEnfermedad renal terminal | sin fecha |
| Completado | Fase 2 | pegfilgrastimCancer de mama | sin fecha |
| Interrumpido | Fase 1/2 | AMG 114Anemia · Cancer | sin fecha |
| Ya no disponible | no aplica | AMG 714AMG 714 Expanded Access Program | sin fecha |
| Completado | Fase 2 | anakinraArtritis reumatoide | sin fecha |
| Completado | Fase 2 | pegfilgrastimLinfoma no Hodgkin | sin fecha |
| Completado | no aplica | Enbrel®Artritis reumatoide | sin fecha |
| Completado | Fase 3 | Etanercept LiquidArtritis reumatoide | sin fecha |
| Completado | Fase 4 | darbepoetin alfaEnfermedad renal cronica · Insuficiencia renal cronica · Enfermedad renal · Prediálisis · Pre-ESRD | sin fecha |
| Completado | Fase 4 | EtanerceptArtritis reumatoide | sin fecha |
| Completado | Fase 2 | darbepoetin alfaNeoplasias · Anemia | sin fecha |
| Completado | Fase 4 | Aranesp®Insuficiencia renal cronica · Anemia | sin fecha |
| Completado | Fase 4 | Enbrel®Psoriasis | sin fecha |
| Completado | Fase 4 | Aranesp®Enfermedad renal en etapa terminal | sin fecha |
| Ya no disponible | no aplica | Blinatumomab · RIALTOExpanded Access Protocol - Blinatumomab in Pediatric & Adolescent Subjects With Relapsed/Refractory B-precursor ALL | sin fecha |
| Completado | Fase 4 | Aranesp®Enfermedad renal | sin fecha |
| Completado | Fase 3 | Recombinant Human Keratinocyte…Estomatitis | sin fecha |
| Completado | Fase 2 | CCX282-BSafety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease | sin fecha |
| Completado | Fase 1 | AMG 386Tumores | sin fecha |
| Completado | Fase 1/2 | darbepoetin alfaA Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects | sin fecha |
| Completado | Fase 2 | ABX-EGFCancer colorrectal | sin fecha |
| Sin noticias del promotor | Fase 2 | filgrastimCancer de pulmon | sin fecha |
| Completado | Fase 3 | AnakinraArtritis reumatoide | sin fecha |
| Completado | Fase 1 | HPN-100A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group | sin fecha |
| Ya no disponible | no aplica | AMG 510Expanded Access of Sotorasib | sin fecha |
| Completado | Fase 1 | FilgrastimInfeccion por VIH | sin fecha |
| Aprobado para comercializar | no aplica | CarfilzomibMieloma multiple | sin fecha |
| Completado | Fase 2 | ABX-EGFCancer colorrectal metastasico | sin fecha |
| Completado | Fase 1 | HPN-100Voluntarios sanos | sin fecha |
| Completado | Fase 2 | Darbepoetin AlfaSindromes mielodisplasicos | sin fecha |
| Completado | Fase 3 | pegfilgrastimcancer de mama | sin fecha |
| Completado | Fase 3 | Aranesp®Enfermedad renal | sin fecha |
| Completado | Fase 2 | CinacalcetEnfermedad renal terminal | sin fecha |
| Completado | no aplica | Sensipar®A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD) | sin fecha |
| Completado | no aplica | Sensipar after Post TransplantPost Transplant Study | sin fecha |
| Completado | Fase 3 | darbepoetin alfaanemia | sin fecha |